Chen, Y.-A.; Tzeng, D.T.W.; Huang, Y.-P.; Lin, C.-J.; Lo, U.-G.; Wu, C.-L.; Lin, H.; Hsieh, J.-T.; Tang, C.-H.; Lai, C.-H.
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers 2019, 11, 34.
https://doi.org/10.3390/cancers11010034
AMA Style
Chen Y-A, Tzeng DTW, Huang Y-P, Lin C-J, Lo U-G, Wu C-L, Lin H, Hsieh J-T, Tang C-H, Lai C-H.
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers. 2019; 11(1):34.
https://doi.org/10.3390/cancers11010034
Chicago/Turabian Style
Chen, Yu-An, David T. W. Tzeng, Yi-Ping Huang, Chun-Jung Lin, U-Ging Lo, Chia-Lin Wu, Ho Lin, Jer-Tsong Hsieh, Chih-Hsin Tang, and Chih-Ho Lai.
2019. "Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways" Cancers 11, no. 1: 34.
https://doi.org/10.3390/cancers11010034
APA Style
Chen, Y. -A., Tzeng, D. T. W., Huang, Y. -P., Lin, C. -J., Lo, U. -G., Wu, C. -L., Lin, H., Hsieh, J. -T., Tang, C. -H., & Lai, C. -H.
(2019). Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers, 11(1), 34.
https://doi.org/10.3390/cancers11010034